uso de inhibidores de la bomba de

263 Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selectiveserotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding; a population based cohortstudy. Arch Intern Med. 2003; 163(1): 59-64.264 Meijer WEE, Heerdink ER, Nolen WA, Herings RMC, Leufkens HGM, Egberts ACG. Association ofrisk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch InternMed. 2004; 164(23): 67-70.265 Van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake byantidepressants and upper gastroinstestinal bleeding in elderly patients: retrospective cohort study. BMJ.2001; 323: 1-6.266Woolfrey S, Gammack NS, Dewar MS, Brown PJ. Fluoxetine-warfarin interaction. BMJ.1993;307:241.267 Hanger HC, Thomas F. Fluoxetine and warfarin interactions. N Z Med J. 1995;108:157.268 Dent LA, Orrock MW. Warfarin-fluoxetine and diazepam-fluoxetine interaction. Pharmacotherapy.1997;17:170-2.269 Holbrook AM, Pereira JA, Labiris R, McDonald H, James D. Douketis JD, et al. Systematic Overviewof Warfarin and Its Drug and Food Interactions. Arch Intern Med. 2005; 165: 1095-1106.270 Schalekamp T, Klungel JH, Souverein PC, de Boer A. Increased Bleeding Risk With Concurrent Useof Selective Serotonin Reuptake Inhibitors and Coumarins. Arch Intern Med. 2008; 168: 180-185.271 Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences betweenpractitioners. Br J Gen Pract. 1999; 49: 195-198.272 Pérez Fuentes MF, Castillo Castillo R, Rodríguez Toquero J, Martos López E, Morales Mañero A.Adecuación del tratamiento farmacológico en población anciana polimedicada. Med Fam. 2002; 1: 23-28.111